Arcobaleno Cancer Trust
Also known as: Act
Our aim is to support the advancement of medical research into the causes, treatments, and potential cures for all types of cancer. We plan to do so by directly funding the individuals and projects pioneering cutting edge cancer research in the UK
Activities & Mission
Our aim is to support the advancement of medical research into the causes, treatments, and potential cures for all types of cancer. We plan to do so by directly funding the individuals and projects pioneering cutting edge cancer research in the UK
Grants
Arcobaleno Cancer Trust is a grant-making charity: making grants is its main activity.
- Gives grants to
- organisations and individuals
- Total spending (2025)
- £191,379
- Only charities with income over £500,000 file a separate grants figure.
- Who it helps
- the general public
- What it supports
- general charitable purposes, the advancement of health or the saving of lives and disability
As recorded with the Charity Commission. To ask about applying, use the contact details and check the trustees and latest accounts below.
Is this your charity?
Add your logo, photos and tell the story behind the numbers in your own words. Free for our first 50 launch partners.
Claim this listing Learn more about premium profiles See a sample profileAreas of Operation
Where this charity is registered to operate, as self-declared to the Charity Commission. These are regulatory classifications, not a list of active programmes, and don't necessarily indicate fundraising activity in each location.
Region
Financial Information
Financial Efficiency
Financial Trend
Annual Returns
As filed with the Charity Commission for England and Wales. Most recent filing covers the financial year ending 2025.
One or more years show a significant change in income (over ±100%) compared with the prior year. This usually reflects a merger, transfer of activities, restated accounts, or a one-off legacy — not necessarily a real change in operating scale. See the methodology for context.
| Financial Year | Income | Expenditure | Charitable Spending | Net Assets | Reserves | Staff |
|---|---|---|---|---|---|---|
| 2025 | £117,217 | £191,379 | 0 / 40 | |||
| 2024 | £36,245 | £60,627 | 0 / 12 | |||
| 2023 | £91,301 | £132,750 | 0 / 36 | |||
| 2022 | £70,283 | £88,346 | 0 / 33 | |||
| 2021 | £236,955 | £25,939 | 0 / 5 |
Staff column shows: Employees / Volunteers
Frequently asked questions about Arcobaleno Cancer Trust
What does Arcobaleno Cancer Trust do?
Our aim is to support the advancement of medical research into the causes, treatments, and potential cures for all types of cancer. We plan to do so by directly funding the individuals and projects pioneering cutting edge cancer research in the UK
How much income did Arcobaleno Cancer Trust report in 2025?
Arcobaleno Cancer Trust reported total income of £117k and reported expenditure of £191k for the financial year ending 2025, based on the most recent annual return filed with the Charity Commission.
When was Arcobaleno Cancer Trust registered as a charity?
Arcobaleno Cancer Trust was registered with the Charity Commission for England and Wales on 15 January 2018 as charity number 1176652. It has been registered for 8 years.
Who runs Arcobaleno Cancer Trust?
Arcobaleno Cancer Trust is governed by a board of 7 trustees. Trustees are legally responsible for the charity's governance and are listed in full on its profile.
Where does Arcobaleno Cancer Trust operate?
Arcobaleno Cancer Trust operates in England, as recorded in its Charity Commission filing.
Is Arcobaleno Cancer Trust a registered charity?
Yes — Arcobaleno Cancer Trust is a registered charity in England and Wales, charity number 1176652.
Is this your charity?
Add your logo, photos and tell the story behind the numbers in your own words. Free for our first 50 launch partners.
Claim this listing Learn more about premium profiles See a sample profileDetails
Registry Information
Trustees
Also governs 1 other charity
Also governs 1 other charity
Also Known As
- Act
Data & trust
- Register data refreshed
- 26 October 2026
- Methodology
- How metrics are calculated